121 related articles for article (PubMed ID: 35913833)
1. Paradoxical feeding activation of gut lipophagy by FGF15/FGF19-NR0B2/SHP-TFEB.
Seok S; Kemper JK
Autophagy; 2023 Feb; 19(2):742-743. PubMed ID: 35913833
[TBL] [Abstract][Full Text] [Related]
2. Feeding activates FGF15-SHP-TFEB-mediated lipophagy in the gut.
Seok S; Kim YC; Zhang Y; Kong B; Guo G; Ma J; Kemper B; Kemper JK
EMBO J; 2022 Sep; 41(17):e109997. PubMed ID: 35686465
[TBL] [Abstract][Full Text] [Related]
3. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
[TBL] [Abstract][Full Text] [Related]
4. A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy.
Byun S; Kim YC; Zhang Y; Kong B; Guo G; Sadoshima J; Ma J; Kemper B; Kemper JK
EMBO J; 2017 Jun; 36(12):1755-1769. PubMed ID: 28446510
[TBL] [Abstract][Full Text] [Related]
5. Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A.
Kim YC; Seok S; Zhang Y; Ma J; Kong B; Guo G; Kemper B; Kemper JK
Nat Commun; 2020 Nov; 11(1):5969. PubMed ID: 33235221
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease.
Kim YC; Qi M; Dong X; Seok S; Sun H; Kemper B; Fu T; Kemper JK
J Biol Chem; 2023 Aug; 299(8):104946. PubMed ID: 37348559
[TBL] [Abstract][Full Text] [Related]
7. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
[TBL] [Abstract][Full Text] [Related]
8. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
[TBL] [Abstract][Full Text] [Related]
9. Liver ChIP-seq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2.
Kim YC; Byun S; Zhang Y; Seok S; Kemper B; Ma J; Kemper JK
Genome Biol; 2015 Dec; 16():268. PubMed ID: 26634251
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
[TBL] [Abstract][Full Text] [Related]
12. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice.
Kong B; Wang L; Chiang JY; Zhang Y; Klaassen CD; Guo GL
Hepatology; 2012 Sep; 56(3):1034-43. PubMed ID: 22467244
[TBL] [Abstract][Full Text] [Related]
14. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A
FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A.
Jahn D; Sutor D; Dorbath D; Weiß J; Götze O; Schmitt J; Hermanns HM; Geier A
Biochim Biophys Acta; 2016 Feb; 1859(2):381-92. PubMed ID: 26723851
[TBL] [Abstract][Full Text] [Related]
16. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
17. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
18. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
[TBL] [Abstract][Full Text] [Related]
19. Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development.
Schumacher JD; Kong B; Wu J; Rizzolo D; Armstrong LE; Chow MD; Goedken M; Lee YH; Guo GL
Hepatology; 2020 Feb; 71(2):670-685. PubMed ID: 31206730
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling.
Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM
Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
